Skip to content

The Effect of Emotion Regulation Training on Anxiety, in College Students in Egypt

The Effect of Emotion Regulation Training on Anxiety, in College Students in Egypt During COVID-19

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04932369
Enrollment
200
Registered
2021-06-21
Start date
2021-04-01
Completion date
2022-05-01
Last updated
2022-07-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety, Emotion Regulation

Keywords

University's students, COVID-19

Brief summary

The important role of Emotion Regulation (ER) in managing stress and anxiety is well recognized. Aims: 1) assessing the level of anxiety, and the level of difficulties in emotion regulation (DER) among University Students during COVID-19, 2) investigating the effect of the emotional regulation training program on the anxiety of University Students during the COVID-19. Methods: Part I, students will be assessed for their anxiety, DER, and the general impact of COVID-19 on their lives. The students will complete Beck Anxiety Inventory (BAI) and Difficulties in Emotion Regulation Scale (DERS). Part II will be a Randomized Control Trial (RCT) using a pre-assessment and a post-assessment. A voluntary sample of students will randomly assigned to either a group that will receive emotion regulation training or a control group. The training program is an adapted version of DBT skills training. The training program will include mindfulness, emotion regulation, and problem-solving skills through eight 90- min group sessions.

Interventions

BEHAVIORALEmotion Regulation training based on DBT

trained about emotion regulation and problem solving during eight 90-min group sessions

Sponsors

British University In Egypt
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
15 Years to 30 Years
Healthy volunteers
Yes

Inclusion criteria

* Being an active student at the University

Exclusion criteria

1. Receiving treatment at the hospital during the time that the study was in progress 2. Having been diagnosed with psychotic disorders 3. Having mental retardation

Design outcomes

Primary

MeasureTime frameDescription
Change in anxiety from Baseline to the completion of training three months later using Beck Anxiety Inventory (BAI)3 months. Assessments of anxiety will be collected from all students two times, three months apartBeck Anxiety Inventory (BAI): was developed by Dr. Aaron T. Beck and it is a brief measure of anxiety with a focus on somatic symptoms of anxiety such as nervousness, dizziness, inability to relax (Beck et al., 1988). It has a total of 21 items that takes approximately 10-15 minutes to complete. Answers are on a 4-point Likert scale and range from 0 (not at all) to 3 (severely). The values for each item are added together to get an overall or total score for all 21 symptoms that can vary from 0 to 63 points. A total score of 0 - 7 indicates Minimal anxiety; 8 - 15 indicates Mild anxiety; 16 -25 indicates Moderate anxiety; and 26 - 63 indicates Severe anxiety
Change in difficulties in emotion regulation from Baseline to the completion of training three months later using Emotion regulation difficulties Scale3 months. Assessments of DER will be collected from all students two times, three months apartThe DERS is a 36-item self-reported questionnaire that assesses an individual's ability to regulate their emotions (Gratz & Roemer, 2004). Participants rate items on a 5-point Likert scale (1 = seldom to 5 = nearly frequently) to represent their self-perceived reactions to stressful emotional situations. The DERS produces an overall difficulty score in ER as well as six subscales: (a) Awareness, (b) Clarity, (c) Nonacceptance, (d) Impulsivity, (e) Goals, and (f) Strategies. Subscales are evaluated in such a way that higher values imply more difficulty.

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026